TOPLINEOn Tuesday, biopharmaceutical company Moderna announced that the Food and Drug Administration is fast tracking its experimental preventative COVID-19 vaccine through the regulatory process. Moderna has received $500 million in federal cash to back development of the vaccine, according to Forbes. There is no vaccine or cure for coronavirus, and the vaccine is held up by top experts as the best hope of returning to life pre-COVID-19. Coronavirus has been an exception—with pharma companies racing alongside governments around the world to develop a vaccine to battle the pandemic. Further ReadingFueled By $500 Million In Federal Cash, Moderna Races To Make A Billion Doses Of An Unproven Cure (Forbes)Moderna's experimental coronavirus vaccine gets FDA's 'fast track' status (Reuters)Latest on global search for coronavirus vaccine: 1st US candidate set for Phase 2; WHO tracks 8 efforts; Pfizer tests in humans (USA Today)Fast Track (Food and Drug Administration)Full coverage and live updates on the Coronavirus

Source: Forbes May 12, 2020 14:26 UTC